3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
5
Terminated
3
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Nasopharyngeal Carcinoma
20
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
7
Prostatic Neoplasms
5
Carcinoma
4
Rectal Neoplasms
3
Nasopharyngeal Neoplasms
3
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Stomatitis
2
Pancreatic Adenocarcinoma
2
Neoplasm Metastasis
2
Meningeal Carcinomatosis
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Tumor Virus Infections
1
Thyroid Carcinoma, Anaplastic
1
Stomatognathic Diseases
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Sarcoma
1
Recurrence
1
Interventions
Doxorubicin
15
pembrolizumab
12
Cyclophosphamide
9
Surgical Procedures, Operative
8
Gemcitabine
8
Blood Specimen Collection
8
Ifosfamide
7
Surveys and Questionnaires
6
Nivolumab
6
Trabectedin
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Drug Therapy
5
fludarabine
4
Temozolomide
4
Specimen Handling
4
Radiation Dose Hypofractionation
4
Biopsy
4
selinexor
3
pazopanib
3
liposomal doxorubicin
3
cabozantinib
3
atezolizumab
3
anlotinib
3
Radiation
3
Observation
3
Docetaxel
3
Dacarbazine
3
trastuzumab deruxtecan
2
toripalimab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Sarcoma
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT06022159
2025-06-05
HYPOSARC
Institut Claudius Regaud
Phase 2
Recruiting
48 enrolled